These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8907199

  • 1. Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study.
    Linassier C, Fouillard L, Milpied N, Tilly H, Pico J, Abgrall JF, Coiffier B, Herbrecht R, Biron P, Colombat P.
    Cancer Detect Prev; 1996; 20(1):11-9. PubMed ID: 8907199
    [Abstract] [Full Text] [Related]

  • 2. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.
    Colombat P, Donadio D, Fouillard L, Milpied N, Tilly H, Pico J, Abgrall JF, Coiffier B, Herbrecht R, Philip T.
    Bone Marrow Transplant; 1994 Feb; 13(2):157-62. PubMed ID: 8205084
    [Abstract] [Full Text] [Related]

  • 3. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 4. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B, Milpied N, Mellerin MP, Moreau P, Morineau N, Vigier M, Harousseau JL.
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [Abstract] [Full Text] [Related]

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 6. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
    Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN.
    Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [Abstract] [Full Text] [Related]

  • 8. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
    Subirà M, Sureda A, Martino R, García J, Altés A, Canals C, Domingo-Albós A, Brunet S, Sierra J.
    Haematologica; 2000 Feb; 85(2):167-72. PubMed ID: 10681724
    [Abstract] [Full Text] [Related]

  • 9. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM, Honegger HP, Stahel RA.
    Schweiz Med Wochenschr; 2000 Jan 22; 130(3):60-9. PubMed ID: 10683881
    [Abstract] [Full Text] [Related]

  • 10. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
    Zhou SY, Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou AP, Feng FY.
    Ai Zheng; 2002 Apr 22; 21(4):405-8. PubMed ID: 12452021
    [Abstract] [Full Text] [Related]

  • 11. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS.
    Ann Hematol; 2005 Aug 22; 84(8):526-31. PubMed ID: 15915350
    [Abstract] [Full Text] [Related]

  • 12. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
    Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW, Wong RM, Blume KG.
    Biol Blood Marrow Transplant; 1996 May 22; 2(2):76-85. PubMed ID: 9118302
    [Abstract] [Full Text] [Related]

  • 13. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 22; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

  • 14. High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Sweetenham JW, Taghipour G, Milligan D, Blystad AK, Caballero D, Fassas A, Goldstone AH.
    Bone Marrow Transplant; 1997 Nov 22; 20(9):745-52. PubMed ID: 9384476
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D.
    Bone Marrow Transplant; 1999 Sep 22; 24(5):473-81. PubMed ID: 10482930
    [Abstract] [Full Text] [Related]

  • 16. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
    Wang H, Cui X, Shao Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 22; 23(5):436-8. PubMed ID: 11810783
    [Abstract] [Full Text] [Related]

  • 17. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
    Kleiner S, Kirsch A, Schwaner I, Kingreen D, Schwella N, Huhn D, Siegert W.
    Bone Marrow Transplant; 1997 Dec 22; 20(11):953-9. PubMed ID: 9422474
    [Abstract] [Full Text] [Related]

  • 18. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.
    Neoplasma; 2001 Dec 22; 48(6):501-5. PubMed ID: 11949845
    [Abstract] [Full Text] [Related]

  • 19. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S.
    Bone Marrow Transplant; 1999 Oct 22; 24(8):865-72. PubMed ID: 10516698
    [Abstract] [Full Text] [Related]

  • 20. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
    Bone Marrow Transplant; 2000 Nov 22; 26(10):1051-6. PubMed ID: 11108302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.